Trademark Overview
On Tuesday, June 24, 2025, a trademark application was filed for MYRUSPA with the United States Patent and Trademark Office. The USPTO has given the MYRUSPA trademark a serial number of 99249230. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 24, 2025. This trademark is owned by Glaxo Group Limited. The MYRUSPA trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of of infectious diseases